Next stop IPO? Olema adds to momentum with $85M series C

Two weeks after former AstraZeneca CMO Sean Bohen took over as president and CEO, Olema has raised $85 million in a series C round led by Vivo Capital.

The San Francisco company’s next financing may well come via an IPO as the round added at least three more crossover investors to a syndicate that already includes nearly 10 such firms. Olema raised a crossover-laden $54 million series B round in July. ...